Details for New Drug Application (NDA): 062520
✉ Email this page to a colleague
The generic ingredient in KANAMYCIN SULFATE is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for 062520
Tradename: | KANAMYCIN SULFATE |
Applicant: | Watson Labs |
Ingredient: | kanamycin sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062520
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/3ML | ||||
Approval Date: | May 9, 1985 | TE: | RLD: | No |
Complete Access Available with Subscription